The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.20
Bid: 63.20
Ask: 65.40
Change: 0.00 (0.00%)
Spread: 2.20 (3.481%)
Open: 64.20
High: 0.00
Low: 0.00
Prev. Close: 64.20
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

27 Nov 2018 07:00

RNS Number : 5496I
IDOX PLC
27 November 2018
 

27 November 2018

Idox plc

('Idox' or the 'Group' or the 'Company')

Year End Trading Update

 

ldox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today issues a trading update for the twelve months ended 31 October 2018. 

The Group continues the transition to fully consolidate prior year acquisitions and refocus operations on our core profitable and cash generative activities to maximise shareholder value. As announced on 2 November 2018, the Group took the strategic decision to dispose of its loss-making Digital business.

The Group expects to report:

· consolidated revenues for the continuing business (excluding our Digital business disposed of on 2 November 2018) of £67.2m (2017: £73.5m restated). Consolidated revenues for the full year of all Group operations including our disposed Digital Business are expected to be £73.6m (2017: £86.3m restated).

· adjusted EBITDA† for the continuing business (excluding our Digital business disposed of on 2 November 2018) of £14.4m (2017: £16.7m restated). Adjusted EBITDA for the full year of all Group operations including our disposed Digital Business is expected to be £11.5m (2017: £16.1m restated).

· net debt position at 31 October 2018 of £31.7m (2017: £32.8m) comprising cash of £5.5m, third party borrowings of £25.7m and long term 2025 bond of £11.5m (2017: cash of £3.3m, third party borrowings of £24.7m and long term, 2025 bond of £11.4m)

The Group has appointed a new leadership team to drive value in the business with the appointment of Chris Stone as Non-Executive Chairman, Dave Meaden as Chief Executive Officer and Rob Grubb as Chief Financial Officer.

The Group has made progress with its core business in adjusting revenue profiles to align with the performance obligations of the services and solutions we deliver to our customers. The Group has also been focused on reducing the cost base to more appropriately match our business model to drive increased profitability and tightly manage working capital to ensure improved cash conversion.

The following provides an update on all these objectives, and excludes the Digital business to illustrate trends in the remaining core businesses of the Group going in to FY2019:

· Exit annualised recurring revenue run rate as at 31 October 2018 was £32.4m (as at 31 October 2017: £33.4m restated). Sustaining and improving levels of recurring revenues remains a priority.

· Our contracted order book for software and services has nearly doubled to £9.4m at 31 October 2018 (2017: approximately £4.0m), an increase of £5.4m reflecting revenue recognition commensurate with our performance obligations.

· Trade debtors and accrued income was £30.8m at 31 October 2018 (2017: £39.0m restated). The Group has a clear objective to reduce this further going into FY2019 and achieve higher cash conversion from its previous and ongoing activities.

· Our preparation for IFRS 15 has led to detailed review of how we recognise revenue in line with our performance obligations. As a result, it is anticipated that recurring revenues will form a higher proportion of the Group's revenues going forward compared to previous years.

· The majority of cost cutting during the year occurred in the now disposed Digital division. As part of the focus on increased profitability, costs in the continuing business (including employment costs, travel, marketing and other overheads) have reduced by £1.7m for the year ended 31 October 2018 to £44.0m (2017: £45.7m). This trend is expected to continue in to FY2019 and beyond as the Group adjusts its cost base to align more directly with its re-focused business model and drive increased profitability.

The Group expects to issue its FY2018 preliminary results announcement in February 2019.

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition, corporate finance and share option costs.

 

David Meaden, Chief Executive of Idox, commented:

"FY2018 has seen a number of changes in the Idox business, but we end the financial year in a stronger position than we entered it and I am confident in our new leadership and team to deliver success in FY2019.

We continue to work hard to fully integrate prior year acquisitions and refocusing operations on our intellectual property and profitable cash generative activities. 

I am excited by the prospects for the business in FY2019 and future periods as we begin to reap the benefits of these ongoing efforts."

 

-Ends-

This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the trading update described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Enquiries:

Idox plc

+44 (0) 870 333 7101

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

N+1 Singer (NOMAD and Broker)

+44 (0) 20 7496 3000

Shaun Dobson / Jen Boorer (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUNARRWKAAUUA
Date   Source Headline
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights
27th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 20237:00 amRNSYear End Trading Update
9th Nov 202310:25 amRNSHolding(s) in Company
6th Nov 20233:01 pmRNSHolding(s) in Company
2nd Nov 20232:10 pmRNSHolding(s) in Company
2nd Nov 202310:09 amRNSHolding(s) in Company
1st Nov 202311:48 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAdoption of New LTIP and Grant of Options
4th Oct 20237:00 amRNSExercise of Share Options & Total Voting Rights
25th Sep 202310:06 amRNSHolding(s) in Company
11th Sep 20237:00 amRNSExercise of Share Options & Total Voting Rights
31st Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
21st Aug 20237:00 amRNSAcquisition
4th Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
3rd Aug 20231:49 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSChange of Registered Address
14th Jul 20237:00 amRNSExercise of Share Options & Total Voting Rights
27th Jun 20237:00 amRNSExercise of Share Options & Total Voting Rights
13th Jun 20237:00 amRNSPayment of Earnout and Allotment of Shares
12th Jun 20234:44 pmRNSHolding(s) in Company
8th Jun 20237:00 amRNSHalf Year results
18th May 20237:00 amRNSHalf Year 2023 Trading Update
23rd Mar 20232:33 pmRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Trading Update
3rd Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
15th Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
9th Feb 202311:03 amRNSHolding(s) in Company
3rd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSFinal Results
11th Jan 20237:00 amRNSNotice of Final Results
15th Dec 20227:00 amRNSPayment of Earnout and Allotment of Shares
8th Dec 20221:17 pmRNSHolding(s) in Company
16th Nov 20227:00 amRNSTrading Statement
14th Nov 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.